Although COPD and liver disease are widely recognized as consequences of inadequate or aberrant AAT, there are other potential consequences of AATD, including autoimmune diseases, type 1 and type 2 diabetes, and obesity. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.